On October 19, 2009, Aptiom, Inc., an indirect wholly-owned subsidiary of Dainippon Sumitomo Pharma Co., Ltd. completed its subsequent tender offer for Sepracor Inc. (“SEPR”) Common Shares. The merger was subsequently consummated on October 20, 2009. As a result, each existing SEPR Common Share will be converted into the right to receive $23.00 net cash per share.
This action will be coordinated with the Options Clearing Corporation.
CME Group is the world's leading and most diverse derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.